FDA panel backs first-of-its-kind flu vaccine using mRNA technologyPublished byapnews.comon •1 min readA sign marks an entrance to a Moderna building in Cambridge, Mass., May 18, 2020. (AP Photo/Bill Sikes, File)prntoImmunizationsFluMedicationU.S. Food and Drug AdministrationGeneral newsRobert F. Kennedy Jr.Timothy BrennanScienceHayley GansBusinessHealthU.S. newsFlor Munoz-RivasModernaInc.Learn moreShareLegalReport
